TCT 221: Global Insights from the TRICUS Registry: Real-World Outcomes with TricValve Bi-Caval Valve Therapy for Tricuspid Regurgitation    

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Grant Support/Research Contract - Abbott</li><li>Consultant Fee/Honoraria/Speaker’s Bureau - Abbott; Bristol-Myers Squibb; Edwards Lifesciences; P+F Products * Features GmbH; Philips</li></ul>